D. Scott Neal, Inc. Pfizer Inc Transaction History

D. Scott Neal, Inc.

$188 Million
Q3 2024

A detailed history of D. Scott Neal, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, D. Scott Neal, Inc. holds 7,029 shares of PFE stock, worth $187,955. This represents 0.11% of its overall portfolio holdings.

Number of Shares

7,029

Holding current value

$187,955

% of portfolio

0.11%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$27.7 - $31.39 $194,703 - $220,640	7,029 New	7,029 $203,000
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $2,672 - $3,092	-74 Reduced 1.04%	7,029 $257,000
Q1 2023 Apr 12, 2023	SELL	$39.39 - $51.28 $338,754 - $441,008	-8,600 Reduced 54.77%	7,103 $289,000
Q4 2022 Jan 11, 2023	SELL	$41.75 - $54.5 $24,799 - $32,373	-594 Reduced 3.64%	15,703 $0
Q1 2022 May 04, 2022	BUY	$45.75 - $56.69 $183,000 - $226,760	4,000 Added 32.53%	16,297 $844,000
Q4 2021 Jan 21, 2022	SELL	$41.32 - $61.25 $82,061 - $121,642	-1,986 Reduced 13.9%	12,297 $726,000
Q3 2021 Nov 04, 2021	BUY	$39.25 - $50.42 $2,904 - $3,731	74 Added 0.52%	14,283 $614,000
Q2 2021 Aug 02, 2021	BUY	$35.91 - $40.68 $359 - $406	10 Added 0.07%	14,209 $556,000
Q1 2021 Apr 30, 2021	SELL	$33.49 - $37.77 $279,574 - $315,303	-8,348 Reduced 37.02%	14,199 $514,000
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $9,706 - $12,342	290 Added 1.3%	22,547 $829,000
Q1 2020 Apr 27, 2020	BUY	$27.03 - $38.62 $332,090 - $474,485	12,286 Added 123.22%	22,257 $726,000
Q4 2019 Jan 16, 2020	SELL	$32.92 - $37.36 $32,097 - $36,426	-975 Reduced 8.91%	9,971 $391,000
Q3 2019 Oct 16, 2019	BUY	$32.49 - $42.13 $3,996 - $5,181	123 Added 1.14%	10,946 $393,000
Q2 2019 Jul 25, 2019	SELL	$36.98 - $41.52 $3,106 - $3,487	-84 Reduced 0.77%	10,823 $469,000
Q1 2019 Apr 11, 2019	BUY	$37.5 - $41.2 $3,150 - $3,460	84 Added 0.78%	10,907 $463,000
Q4 2018 Feb 06, 2019	SELL	$38.47 - $43.86 $10,194 - $11,622	-265 Reduced 2.39%	10,823 $472,000
Q1 2018 Apr 19, 2018	SELL	$31.91 - $37.02 $319 - $370	-10 Reduced 0.09%	11,088 $394,000
Q4 2017 Feb 16, 2018	BUY	$33.26 - $35.29 $249,283 - $264,498	7,495 Added 208.02%	11,098 $402,000
Q3 2017 Oct 18, 2017	BUY	$31.0 - $34.15 $111,693 - $123,042	3,603	3,603 $129,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.8 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.77 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.38 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.48 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. Scott Neal, Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. Scott Neal, Inc. with notifications on news.

Account